Articles by Brad Miles - Pharmaceutical Executive


Articles by Brad Miles

Value Today for Drugs Tomorrow

The industry can help its bad rep by communicating the promise of its pipeline—and the value of its companies.
Oct 1, 2005

Fda-approved drugs represent a company's prospects today. Drugs in the pipeline embody the company's future. But when it comes to analyzing the value of a pharma company, the pipeline is often overlooked.


Click here